Developing Innovative Ligands for Nuclear Receptors to Eradicate Cancer Relapse

The aim of the Marie Sklodowska-Curie Doctoral Network “eRaDicate” is to develop new therapies against cancer stem cell-driven relapse and metastasis. Our 11 doctoral candidates (DCs) of eRaDicate will be trained not only to perform original and independent research on an internationally competitive level, but will also be endowed with a creative, critical and entrepreneurial mindset, coupled with persistence in following their objectives.

eRaDicate is hiring!

We are currently recruiting a Doctoral Candidate (DC) for a PhD position at the University of Wrocław in the field of leukaemia research. Deadline 31.03.2026. All information for the application can be found on the Euraxess page.

The application documents can be downloaded here:
Application form 
Referee form

Please note that only complete applications will  be considered. This includes the application form, research exposé. academic CV, graduation certificates, proof of English language proficiency, valid ID & proof of eligibility, and two letters of refernce & referee form (to be submitted by the referees). See the Euraxess job offer for all the details.

The eRaDicate consortium consists of eight academic and one industrial and beneficiaries, as well as twelve associated partners to provide training and secondments.

Associated Partners